{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T04:49:01Z","timestamp":1766292541376,"version":"3.41.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Aripiprazole is an atypical antipsychotic with a long half-life. Overdose can result in protracted somnolence and cardiac disturbances, particularly QT interval prolongation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a single case report of a 14-year-old boy who took an overdose of aripiprazole and developed QRS widening.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case<\/jats:title><jats:p>A 14-year-old boy intentionally ingested 20 tablets of aripiprazole (5 mg). He was brought to the emergency department when his ingestion was discovered. The patient's vital signs were as follows: temperature, 37.7<jats:bold>\u00b0<\/jats:bold>C; heart rate, 108 beats\/min; blood pressure, 138\/98 mm Hg; and respirations, 16 breaths\/min. Activated charcoal was administered within 90 minutes of ingestion. Initial electrocardiogram (EKG) showed sinus tachycardia, with a QRS of 138 ms and QT interval of 444 ms. QRS duration was 90 ms on an EKG performed 3 months earlier. A bolus of sodium bicarbonate was administered, and the patient was transferred to the pediatric intensive care unit. Repeat EKG demonstrated a QRS of 156 ms, and a sodium bicarbonate infusion was initiated. The patient continued to have QRS prolongation for the next 8 days, reaching a peak of 172 ms 3 days postingestion. Despite aggressive treatment with sodium bicarbonate, there was persistent QRS prolongation; however, the patient did not have any dysrhythmias and remained hemodynamically stable. The patient was discharged 9 days postingestion when the QRS duration normalized to 82 ms. Genetic testing revealed that the patient was a CYP2D6 poor metabolizer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This case suggests that aripiprazole toxicity may possibly be associated with QRS prolongation without associated dysrhythmias or cardiovascular compromise. In addition, toxicity may be prolonged in patients who are CYP2D6 poor metabolizers.<\/jats:p><\/jats:sec>","DOI":"10.1097\/pec.0000000000001502","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T02:49:45Z","timestamp":1525920585000},"page":"e209-e212","source":"Crossref","is-referenced-by-count":9,"title":["Prolonged QRS Widening After Aripiprazole Overdose"],"prefix":"10.1097","volume":"35","author":[{"given":"Maryann","family":"Mazer-Amirshahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Porter","sequence":"additional","affiliation":[{"name":"National Capital Poison Center, Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Dewey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability","volume":"26","year":"2004","journal-title":"Clin Ther"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.ftd.0000249944.42859.bf","article-title":"Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients","volume":"28","year":"2006","journal-title":"Ther Drug Monit"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jemermed.2004.09.013","article-title":"Overdose of aripiprazole, a new type of antipsychotic","volume":"28","year":"2005","journal-title":"J Emerg Med"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajem.2004.10.008","article-title":"One-year experience with aripiprazole exposures","volume":"23","year":"2005","journal-title":"Am J Emerg Med"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1081\/CLT-53095","article-title":"Atypical experience: a case series of pediatric aripiprazole exposures","volume":"43","year":"2005","journal-title":"Clin Toxicol (Phila)"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajem.2008.04.020","article-title":"A systematic review of cardiovascular effects after atypical antipsychotic medication overdose","volume":"27","year":"2009","journal-title":"Am J Emerg Med"},{"key":"bib8-20231002","first-page":"623","article-title":"Outcomes following accidental supratherapeutic aripiprazole (Abilify) ingestions in children and young adults","volume":"45","year":"2007","journal-title":"Clin Toxicol"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s00213-015-4024-9","article-title":"The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach","volume":"232","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/cap.2011.0129","article-title":"The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders","volume":"22","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11095-006-0070-7","article-title":"Effects of antipsychotic drugs on I(to), I(Na), I(sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","year":"2006","journal-title":"Pharm Res"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/eurheartj\/ehl199","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/15563650.2015.1013547","article-title":"Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region","volume":"53","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0022-3565(25)21657-3","article-title":"Mechanism of reversal of toxic effects of amitriptyline on cardiac Purkinje fibers by sodium bicarbonate","volume":"231","year":"1984","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:05:15Z","timestamp":1751630715000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001502","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"type":"electronic","value":"1535-1815"},{"type":"print","value":"0749-5161"}],"subject":[],"published":{"date-parts":[[2018,5,10]]}}}